Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dor Lotan

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Transplantation|March 20, 2024
Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume centerDaniel Oren, Matan Uriel, Cathrine M Moeller, et al.
Circulation. Heart Failure|September 30, 2025
Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New EraCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 30, 2025
Efficacy and safety of belatacept in heart transplant recipientsJulia Baranowska, Daniel Oren, Andrea Fernandez Valledor, et al.
Journal of Cardiac Failure|June 25, 2025
Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients with Moderate to High-Risk CMV SerostatusAfsana Rahman, Changhee Lee, Salwa Rahman, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 16, 2026
De Novo Aortic Insufficiency and Its Progression in Patients on Microaxial Flow Pump Support Before Durable Left Ventricular Assist DeviceBoaz Elad, Kyung T Oh, Daniel Oren, et al.
Clinical Transplantation|October 18, 2024
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ TransplantsCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Clinical Utility of the Molecular Microscope Diagnostic System in a Real-World Transplant Cohort: Moving Towards a New ParadigmAndrea Fernandez Valledor, Cathrine M Moeller, Gal Rubinstein, et al.
JACC. Advances|April 22, 2026
Comparison of Microcirculation in Chronic Heart Failure, Cardiogenic Shock, LVAD, and Heart TransplantationJulia Baranowska, Andrea Fernandez Valledor, Cathrine M Moeller, et al.
Clinical Transplantation|October 14, 2025
Clinical Utility of Combined Donor-Derived Cell-Free DNA and Peripheral Gene-Expression-Profiling in Heart Transplant RecipientsCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Transplantation|March 20, 2024
Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume centerDaniel Oren, Matan Uriel, Cathrine M Moeller, et al.
Circulation. Heart Failure|September 30, 2025
Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New EraCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 30, 2025
Efficacy and safety of belatacept in heart transplant recipientsJulia Baranowska, Daniel Oren, Andrea Fernandez Valledor, et al.
Journal of Cardiac Failure|June 25, 2025
Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Heart Transplant Recipients with Moderate to High-Risk CMV SerostatusAfsana Rahman, Changhee Lee, Salwa Rahman, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 16, 2026
De Novo Aortic Insufficiency and Its Progression in Patients on Microaxial Flow Pump Support Before Durable Left Ventricular Assist DeviceBoaz Elad, Kyung T Oh, Daniel Oren, et al.
Clinical Transplantation|October 18, 2024
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ TransplantsCathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Clinical Utility of the Molecular Microscope Diagnostic System in a Real-World Transplant Cohort: Moving Towards a New ParadigmAndrea Fernandez Valledor, Cathrine M Moeller, Gal Rubinstein, et al.
JACC. Advances|April 22, 2026
Comparison of Microcirculation in Chronic Heart Failure, Cardiogenic Shock, LVAD, and Heart TransplantationJulia Baranowska, Andrea Fernandez Valledor, Cathrine M Moeller, et al.
Clinical Transplantation|October 14, 2025
Clinical Utility of Combined Donor-Derived Cell-Free DNA and Peripheral Gene-Expression-Profiling in Heart Transplant RecipientsCathrine M Moeller, Andrea Fernandez Valledor, Daniel Oren, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
Pageof 7